LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. PMID: 30761122
Re-engineering and evaluation of anti-DNA autoantibody 3E10 for therapeutic applications. PMID: 29374508
DNA-dependent targeting of cell nuclei by a lupus autoantibody. PMID: 26156563
Combining intracellular antibodies to restore function of mutated p53 in cancer. PMID: 26174762
A cell-penetrating antibody inhibits human RAD51 via direct binding. PMID: 29036688
Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells. PMID: 30863489
Ligation of Na, K ATPase β3 subunit on monocytes by a specific monoclonal antibody mediates T cell hypofunction. PMID: 29940031
Engagement of Na,K-ATPase beta3 subunit by a specific mAb suppresses T and B lymphocyte activation. PMID: 12456588
Na, K ATPase beta3 subunit (CD298): association with alpha subunit and expression on peripheral blood cells. PMID: 17176442
DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus. PMID: 7836777
Laboratory evaluation of anti-dsDNA antibodies. PMID: 35016875
The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies. PMID: 34542806
Self-dsDNA in the pathogenesis of systemic lupus erythematosus. PMID: 28836661
Structure and Dynamics of dsDNA in Cell-like Environments. PMID: 36359677
Direct Homologous dsDNA-dsDNA Pairing: How, Where, and Why? PMID: 31726060
Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients. PMID: 35182998
The Effects of Flexibility on dsDNA-dsDNA Interactions. PMID: 35629366
Anti-dsDNA: choice of assay in relation to clinical value. PMID: 1754810
Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies. PMID: 31379858
The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be. PMID: 31156647
Diameter Dependent Melting and Softening of dsDNA Under Cylindrical Confinement. PMID: 35586267
Evidence for charge-based mimicry in anti dsDNA antibody generation. PMID: 36087539
Activation of the NLRP1 inflammasome in human keratinocytes by the dsDNA mimetic poly(dA:dT). PMID: 36693106
A peptide DNA surrogate that binds and inhibits anti-dsDNA antibodies. PMID: 16290070
Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE). PMID: 3304800
Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics. PMID: 31932899
α-2,6-sialic acid/IgG anti-dsDNA ratios correlate with human lupus disease activity and possible mechanisms: A pilot study. PMID: 35531921
Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages. PMID: 27250627
In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation. PMID: 31732191
Precipitating anti-dsDNA peptide repertoires in lupus. PMID: 30086185
Accumulation of cytosolic dsDNA contributes to fibroblast-like synoviocytes-mediated rheumatoid arthritis synovial inflammation. PMID: 31472320
De-sialylated and sialylated IgG anti-dsDNA antibodies respectively worsen and mitigate experimental mouse lupus proteinuria and possible mechanisms. PMID: 35640407
Recognition of DNA Target Formulations by CRISPR-Cas12a Using a dsDNA Reporter. PMID: 34142793
Anti-dsDNA antibodies in sarcoidosis. PMID: 10805357
Thermoresponsive DNA by Intercalation of dsDNA with Oligoethylene-Glycol-Functionalized Small-Molecule Intercalators. PMID: 30725517
In situ dsDNA-bevacizumab anticancer monoclonal antibody interaction electrochemical evaluation. PMID: 26526907
Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. PMID: 20847146
Overstretching partially alkyne functionalized dsDNA using near infrared optical tweezers. PMID: 29339160
Fibroblast growth factor inducible 14 signaling facilitates anti-dsDNA IgG penetration into mesangial cells. PMID: 32542768
Is inflammation a direct response to dsDNA breaks? PMID: 29518635
A brief note on the potential of homo-oligo-dsDNA and hetero-oligo-dsDNA based on their binder-free electrochemical characteristics on gold electrode. PMID: 33832590
Allosteric coupling between Mn2+ and dsDNA controls the catalytic efficiency and fidelity of cGAS. PMID: 32170294
Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection. PMID: 26407840
Protein-coated dsDNA nanostars with high structural rigidity and high enzymatic and thermal stability. PMID: 31578534
Patients with antibodies to both PmScl and dsDNA. PMID: 15517629
Interaction of antitumor flavonoids with dsDNA in the absence and presence of Cu(II). PMID: 23334220
Single-Molecule Methods for Investigating the Double-Stranded DNA Bendability. PMID: 34470919
Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. PMID: 16761503
Single Molecule Study of the Polymerization of RecA on dsDNA: The Dynamics of Individual Domains. PMID: 33842536
Sequence-dependent dsDNA-templated formation of fluorescent copper nanoparticles. PMID: 25510235
Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer. PMID: 28540311
Concatemeric dsDNA-templated copper nanoparticles strategy with improved sensitivity and stability based on rolling circle replication and its application in microRNA detection. PMID: 24958493
Molecular fossils reveal ancient associations of dsDNA viruses with several phyla of fungi. PMID: 32071765
Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. PMID: 12587824
Deciphering the mechanism and binding interactions of Pemetrexed with dsDNA with DNA-targeted chemotherapeutics via spectroscopic, analytical, and simulation studies. PMID: 34875572
The clinical relevance of anti-dsDNA antibodies determined by the Elia™ dsDNA assay in patients with negative indirect immunofluorescence on the HEp-2 cell. PMID: 33064668
Construction of Synthetic Nanobody Library in Mammalian Cells by dsDNA-Based Strategies*. PMID: 34411391
Construction of Peptide Library in Mammalian Cells by dsDNA-Based Strategy. PMID: 36643544
Fast and sensitive diagnosis of autoimmune disorders through amperometric biosensing of serum anti-dsDNA autoantibodies. PMID: 32469729
Ratiometric sensor based on imprinted quantum dots-cationic dye nanohybrids for selective sensing of dsDNA. PMID: 31843675
Anti-dsDNA antibodies in Brazilian patients of mainly African descent with systemic lupus erythematosus: lack of association with lupus nephritis. PMID: 19283331
A novel pathway to detect and cope with exogenous dsDNA. PMID: 27064942
Exploring the Binding Mechanism and Dynamics of EndoMS/NucS to Mismatched dsDNA. PMID: 31627318
Sae2 promotes dsDNA endonuclease activity within Mre11-Rad50-Xrs2 to resect DNA breaks. PMID: 25231868
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort. PMID: 26063969
Melting dynamics of short dsDNA chains in saline solutions. PMID: 26697287
A surge in anti-dsDNA titer predicts a severe lupus flare within six months. PMID: 24316605
An improved measurement of dsDNA elasticity using AFM. PMID: 20090198
ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response. PMID: 30135424
A STING to inflammation and autoimmunity. PMID: 30990921
Goatpoxvirus ATPase activity is increased by dsDNA and decreased by zinc ion. PMID: 27146321
Prognostic value of anti-dsDNA in SLE. PMID: 6981385
The specificity of the anti-dsDNA ELISA. A closer look. PMID: 2040819
Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. PMID: 311204
Multivariate analysis for resolving interactions of carbidopa with dsDNA at a fullerene-C60/GCE. PMID: 24907508
Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus. PMID: 21329504
Concomitance of IgM and IgG anti-dsDNA Antibodies Does Not Appear to Associate to Active Lupus Nephritis. PMID: 24358068
Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus. PMID: 31570052
Manganese porphyrin-dsDNA complex: a mimicking enzyme for highly efficient bioanalysis. PMID: 23427829
Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. PMID: 7642215
Electronic detection of dsDNA transition from helical to zipper conformation using graphene nanopores. PMID: 25325530
Interaction of calf thymus dsDNA with anti-tumor drug tamoxifen studied by zero current potentiometry. PMID: 21524901
In situ electrochemical evaluation of dsDNA interaction with the anticancer drug danusertib nitrenium radical product using the DNA-electrochemical biosensor. PMID: 26523506
Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRLlpr mice. PMID: 9116717
Single molecule identification of homology-dependent interactions between long ssRNA and dsDNA. PMID: 27580717
High Avidity dsDNA Autoantibodies in Brazilian Women with Systemic Lupus Erythematosus: Correlation with Active Disease and Renal Dysfunction. PMID: 26583157
Electrochemical, spectroscopic and molecular docking studies on the interaction of calcium channel blockers with dsDNA. PMID: 30623791
Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. PMID: 11439169
Comparative studies on the interaction of anticancer drug irinotecan with dsDNA and ssDNA. PMID: 35539780
Heterogeneity of anti-dsDNA antibodies in their cross-reaction with ribosomal P protein. PMID: 10585758
Fluorescent cyanine dyes for the quantification of low amounts of dsDNA. PMID: 27507117
The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination. PMID: 29807021
Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. PMID: 16150789
Nonspecific interactions between SpCas9 and dsDNA sites located downstream of the PAM mediate facilitated diffusion to accelerate target search. PMID: 34703564
Defect-Induced Double-Stranded DNA Unwinding on Graphene. PMID: 33689362
[Anti-tumor effect of anti-dsDNA autoantibodies]. PMID: 15946542
International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies. PMID: 27252263
LILBID laser dissociation curves: a mass spectrometry-based method for the quantitative assessment of dsDNA binding affinities. PMID: 33230224
Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients. PMID: 17785320
Ginsenoside Compound K Mitigates Mitochondrial Fission Through Bile Acid Receptors/YAP Signaling to Counteract Podocyte Injury in Lupus Nephritis., PMID:40528637
Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus., PMID:40516124
Luminex-based pilot study identifies novel serum autoantibodies associated with disease activity in patients with lupus nephritis., PMID:40500568
Frequency of the AC-2 pattern's new variant (AC-30) and detection of different immunological relationships., PMID:40482790
SLE complicated with Nocardia farcinica bloodstream infection and disseminated nocardiosis: a case report., PMID:40468247
MBD2 promotes B cell differentiation and BCR signaling in systemic lupus erythematosus by regulating the LEF-1-PTEN-PI3K axis., PMID:40467564
Single-centre comparison of non-familial, familial and monogenic lupus., PMID:40465409
Clinically Relevant Cutoffs for Anti-Extractable Nuclear Antigen Line Immunoassays., PMID:40460086
EXPRESS: Diagnostic Discrepancies: A Retrospective Analysis of Two Anti-Nuclear Antibody Platforms., PMID:40459017
Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumab., PMID:40455606
Double Trouble: A Case Report of Hydralazine-Induced Vasculitis and Lupus., PMID:40443627
The role of IL-39 in autoimmune diseases: From general to immunopathogenesis., PMID:40440970
The effects of SARS-CoV-2 vaccines on antinuclear autoantibody formation in individuals without prior COVID-19 infection., PMID:40424949
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study., PMID:40408235
Targeting Nanotherapeutics for Highly Efficient Diagnosis and Treatment of Systemic Lupus Erythematosus through Regulation of Immune Response., PMID:40395345
Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study., PMID:40377765
A serum biomarker panel and miniarray detection system for tracking disease activity and flare risk in lupus nephritis., PMID:40375995
Effect of rituximab on long-term damage acquisition in patients with systemic lupus erythematosus., PMID:40372703
Validation of eight endotypes of lupus based on whole-blood RNA profiles., PMID:40368437
The hidden pathology: An autopsy diagnosis of unsuspected juvenile systemic lupus erythematosus., PMID:40361200
Differences in dynamics of specific anti-nuclear antibodies and their susceptibility to B cell targeting treatment in Systemic Lupus Erythematosus., PMID:40356198
Umbilical cord mesenchymal stem cell-derived secretome as a potential treatment for systemic lupus erythematosus: A double-blind randomized controlled trial., PMID:40352183
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE., PMID:40350373
Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes., PMID:40343598
Glucocorticoids discontinuation in systemic lupus erythematosus: a single-centre study., PMID:40342521
Delayed seropositive lupus nephritis: a clinical dilemma., PMID:40341080
Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides., PMID:40334619
From Prescription to Predicament: A Case of Semaglutide-Induced Discoid Lupus Erythematosus in an Adult Male Patient., PMID:40330408
Jieduquyuziyin prescription suppresses the activation of the extrafollicular effector B cell by regulating integrin αV signaling in systemic lupus erythematosus., PMID:40318773
Effects of telitacicept in SLE patients with antiphospholipid antibody positivity: a retrospective self-controlled case series., PMID:40317459
Nailfold capillaroscopy changes in systemic lupus erythematosus patients: Correlation with disease activity and anti-uridin1-ribonucleoprotein antibodies., PMID:40316396
Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal study., PMID:40310587
Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients., PMID:40302194
Validation cohort of a tool to predict proliferative histological class in lupus nephritis based on clinical and laboratory data: LUCAS Study (Lupus Nephritis Class Assessment System)., PMID:40294976
Bilateral Periorbital Erythema and Swelling as an Initial Presentation of Systemic Lupus Erythematosus: A Rare Case., PMID:40289991
The Recurrence of Systemic Diseases in Kidney Transplantation., PMID:40283422
Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review., PMID:40283389
Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort., PMID:40276498
Proteomics uncovers ICAM2 (CD102) as a novel serum biomarker of proliferative lupus nephritis., PMID:40274316
Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteria., PMID:40274305
Collapsing Focal Segmental Glomerulosclerosis With Concurrent IgG4 Nephropathy., PMID:40264599
Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis., PMID:40264008
[The effects of S100A9 gene knockout on lupus-like phenotype in mice]., PMID:40260564
Coexistence of antinucleosome and anti-double-stranded DNA antibodies is associated with severe systemic lupus erythematosus in Tunisian patients., PMID:40245259
False Positive C-ANCA Caused by Antinuclear Antibody: a Case Report and Literature Review., PMID:40209788
Isolated anti-ribosomal P antibodies are associated with reduced risk of renal and articular involvement in systemic lupus erythematosus patients. An observational study from one center., PMID:40206226
Application of machine learning in assessing disease activity in SLE., PMID:40204296
A Retrospective Study of Clinical Characteristics and Serological Profile of Male Systemic Lupus Erythematosus Patients in India., PMID:40200610
A novel IgD-FcδR blocker, IgD-Fc-Ig fusion protein, effectively alleviates abnormal activation of T cells the disease progression in systemic lupus erythematosus., PMID:40194603
Construction and evaluation of glucocorticoid dose prediction model based on genetic and clinical characteristics of patients with systemic lupus erythematosus., PMID:40186486
Photothermal Hydrogel with Mn3O4 Nanoparticles Alleviates Intervertebral Disc Degeneration by Scavenging
ROS and Regulating Extracellular Matrix Metabolism. [RGK24020]
For research use only. Not for human or drug use.
